Last Updated : January 15, 2018
Details
FilesGeneric Name:
Fluticasone Furoate and Vilanterol (as trifenatate)
Project Status:
Complete
Therapeutic Area:
Asthma
Manufacturer:
GlaxoSmithKline Inc.
Call for patient/clinician input open:
Brand Name:
Breo Ellipta
Project Line:
Reimbursement Review
Project Number:
SR0442-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Asthma
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Request for Resubmission: Eligible (Decision Date: January 15, 2018)
Files
Last Updated : January 15, 2018